Fayemendy Philippe, Marin Benoit, Labrunie Anaïs, Boirie Yves, Walrand Stéphane, Achamrah Najate, Coëffier Moïse, Preux Pierre-Marie, Lautrette Géraldine, Desport Jean-Claude, Couratier Philippe, Jésus Pierre
Nutrition Unit, University Hospital of Limoges, Limoges, France; INSERM UMR 1094, Tropical Neuroepidemiology, Limoges, France.
INSERM UMR 1094, Tropical Neuroepidemiology, Limoges, France; Center for Epidemiology, Biostatistics and Methodology of Research, University Hospital of Limoges, France.
J Neurol Sci. 2021 Jan 15;420:117257. doi: 10.1016/j.jns.2020.117257. Epub 2020 Dec 3.
Hypermetabolism (HM) in Amyotrophic lateral sclerosis (ALS) is the reflection of a high energy metabolic level, but this alteration seems controversial. The main objective of the study was to confirm the existence of HM during ALS compared to healthy subjects.
A cohort of ALS patients was compared to a control group without metabolic disorder. The assessment included anthropometric criteria measurements, body composition by bioelectric impedance analysis and resting energy expenditure (REE) by indirect calorimetry. HM was defined as a variation > +10% between measured and calculated REE. Statistical analysis used Mann-Withney and Chi2 tests. Multivariate analysis included logistic regression.
287 patients and 75 controls were included. The metabolic level was higher in ALS patients (1500 kcal/24 h [1290-1693] vs. 1230 kcal/24 h [1000-1455], p < 0.0001) as well as the REE/fat free mass ratio (33.5 kcal/kg/24 h [30.4-37.8] vs. 28.3 kcal/kg/24 h [26.1-33.6], p < 0.0001). 55.0% of ALS patients had HM vs. 13.3% of controls (p < 0.0001). HM was strongly and positively associated with ALS (OR = 9.50 [4.49-20.10], p < 0.0001).
HM in ALS is a reality, which affects more than half of the patients and is associated with ALS. This work confirms a very frequent metabolic deterioration during ALS. The identification of HM can allow a better adaptation of the patients' nutritional intake.
肌萎缩侧索硬化症(ALS)中的高代谢(HM)反映了高能量代谢水平,但这种改变似乎存在争议。本研究的主要目的是证实与健康受试者相比,ALS患者中HM的存在。
将一组ALS患者与无代谢紊乱的对照组进行比较。评估包括人体测量标准测量、通过生物电阻抗分析进行身体成分分析以及通过间接量热法测量静息能量消耗(REE)。HM定义为测量的REE与计算的REE之间的变化> +10%。统计分析使用Mann-Withney检验和卡方检验。多变量分析包括逻辑回归。
纳入了287例患者和75例对照。ALS患者的代谢水平更高(1500千卡/24小时[1290 - 1693]对1230千卡/24小时[1000 - 1455],p < 0.0001),REE/去脂体重比也更高(33.5千卡/千克/24小时[30.4 - 37.8]对28.3千卡/千克/24小时[26.1 - 33.6],p < 0.0001)。55.0%的ALS患者有HM,而对照组为13.3%(p < 0.0001)。HM与ALS呈强正相关(OR = 9.50 [4.49 - 20.10],p < 0.0001)。
ALS中的HM是一个现实情况,影响超过一半的患者且与ALS相关。这项研究证实了ALS期间非常常见的代谢恶化。识别HM可以使患者的营养摄入得到更好的调整。